Publications by authors named "Maria Tagliamonte"

Claim this Profile
M
Molecular mimicry as a driver of T cell-mediated tumour immunity.
Jamie Rossjohn, Luigi Nezi, Julianne S Walz, Maria Tagliamonte, Luigi Buonaguro

Trends Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mandatory preventive vaccines for infectious diseases expressing T-cell epitopes for cancer prevention.
Concetta Ragone, Angela Mauriello, Beatrice Cavalluzzo, Simona Mangano, Biancamaria Cembrola, Maria Tagliamonte

Infect Agent Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared neoantigens' atlas for off-the-shelf cancer vaccine development.
Angela Mauriello, Beatrice Cavalluzzo, Concetta Ragone, Maria Tagliamonte, Luigi Buonaguro

J Transl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.
Angeli D G Macandog, Carlotta Catozzi, Mariaelena Capone, Amir Nabinejad, Padma P Nanaware, Maria Tagliamonte

Cell Host Microbe· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization.
Concetta Ragone, Angela Mauriello, Beatrice Cavalluzzo, Ernesta Cavalcanti, Luigi Russo, Maria Tagliamonte

Front Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of shared neoantigens in prevalent mutations in cancer.
Concetta Ragone, Beatrice Cavalluzzo, Angela Mauriello, Maria Tagliamonte, Luigi Buonaguro

J Transl Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-reactive CD8 T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs).
Beatrice Cavalluzzo, Marie Christine Viuff, Siri Amanda Tvingsholm, Concetta Ragone, Carmen Manolio, Maria Tagliamonte

J Exp Clin Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and Dynamic-Based Characterization of the Recognition Patterns of E7 and TRP-2 Epitopes by MHC Class I Receptors through Computational Approaches.
Nicole Balasco, Maria Tagliamonte, Luigi Buonaguro, Luigi Vitagliano, Antonella Paladino

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Primary Human Liver Cancer Cells by Artificial Intelligence-Assisted Raman Spectroscopy.
Concetta Esposito, Mohammed Janneh, Sara Spaziani, Vincenzo Calcagno, Mario Luca Bernardi, Maria Tagliamonte

Cells· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Peptide-based vaccine for cancer therapies.
Luigi Buonaguro, Maria Tagliamonte

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide-based vaccine for cancer therapies.
Luigi Buonaguro, Maria Tagliamonte

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microorganisms-derived antigens for preventive anti-cancer vaccines.
Luigi Buonaguro, Beatrice Cavalluzzo, Angela Mauriello, Concetta Ragone, Anna Lucia Tornesello, Maria Tagliamonte

Mol Aspects Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells.
Tania Mariastella Caputo, Angela Maria Cusano, Sofia Principe, Paola Cicatiello, Giorgia Celetti, Maria Tagliamonte

Int J Nanomedicine· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mimicry and cancer vaccine development.
Maria Tagliamonte, Beatrice Cavalluzzo, Angela Mauriello, Concetta Ragone, Franco M Buonaguro

Mol Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8 T cell immunity in CLL and MDS patients.
Susana Patricia Amaya Hernandez, Ditte Stampe Hersby, Kamilla Kjærgaard Munk, Tripti Tamhane, Darya Trubach, Maria Tagliamonte

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case.
Carmen Manolio, Concetta Ragone, Beatrice Cavalluzzo, Angela Mauriello, Maria Lina Tornesello, Maria Tagliamonte

J Transl Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of antigenic molecular mimicry on anti-cancer T-cell immune response.
Maria Tagliamonte, Luigi Buonaguro

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mimicry between tumor associated antigens and microbiota-derived epitopes.
Concetta Ragone, Carmen Manolio, Angela Mauriello, Beatrice Cavalluzzo, Franco M Buonaguro, Maria Tagliamonte

J Transl Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.
Markus W Löffler, Stefania Gori, Francesco Izzo, Andrea Mayer-Mokler, Paolo A Ascierto, Maria Tagliamonte

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response.
Maria Tagliamonte, Angela Mauriello, Beatrice Cavalluzzo, Concetta Ragone, Carmen Manolio

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoantigens as potential vaccines in hepatocellular carcinoma.
David Repáraz, Marta Ruiz, Diana Llopiz, Leyre Silva, Enric Vercher, Maria Tagliamonte

J Immunother Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines.
Anna Lucia Tornesello, Maria Tagliamonte, Franco M Buonaguro, Maria Lina Tornesello, Luigi Buonaguro

Vaccines (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides.
Angela Mauriello, Beatrice Cavalluzzo, Carmen Manolio, Concetta Ragone, Antonio Luciano, Maria Tagliamonte

J Transl Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Molecular Targets for Hepatocellular Carcinoma.
Beatrice Cavalluzzo, Angela Mauriello, Concetta Ragone, Carmen Manolio, Maria Lina Tornesello, Maria Tagliamonte

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine.
Concetta Ragone, Serena Meola, Pasqualina C Fiorillo, Roberta Penta, Laura Auriemma, Maria Tagliamonte

Front Immunol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis